Deadline: 02-Jul-2026
The Early Career Patient-Oriented Diabetes Research Award is designed to support emerging investigators working in type 1 diabetes clinical research. It focuses on patient-oriented studies where researchers directly interact with human participants. The award helps early-career clinicians build independent research careers in academic medicine and clinical investigation.
The program primarily aims to support the development of clinician-scientists, improve diabetes-related clinical outcomes, and encourage high-quality research involving human subjects in real-world healthcare settings.
Key Features of the Award
The award provides financial and career development support for qualified investigators working in diabetes research. Funding is structured to support both salary-related research effort and project-specific expenses.
- Funding of up to USD 200,000 per year is available.
- The maximum support period is 5 years.
- Indirect costs are limited to 10% of the total award.
- Up to USD 100,000 may be used for research expenses such as technician support, supplies, equipment, and other project needs.
- Travel support of up to USD 2,000 per year may be included for research-related activities.
The research must focus on type 1 diabetes and must involve direct interaction with human participants as part of a clinical or patient-oriented study design.
Research Scope and Requirements
The supported research must be clearly patient-oriented and clinically relevant. It should focus on improving understanding, treatment, or outcomes in type 1 diabetes.
- The research must involve human subjects.
- Investigators must directly interact with study participants.
- Studies should be conducted in clinical, hospital, or real-world healthcare environments.
- The focus must remain on type 1 diabetes and related clinical investigation.
Eligibility Criteria
Institutional Eligibility
Eligible institutions include a wide range of research-performing organizations such as:
- Domestic and international nonprofit organizations
- Public and private universities and colleges
- Hospitals and healthcare systems
- Research laboratories and specialized units
- State and local government agencies
- Eligible federal government agencies
- Both nonprofit and for-profit research institutions (domestic or international)
Investigator Eligibility
Applicants are generally expected to meet the following criteria:
- Hold a clinical or research doctoral degree such as MD, MD-PhD, DO, or PsyD
- Have an appointment or joint appointment in a clinical department
- Be actively engaged in human clinical research
- Have received their first faculty-level appointment within the past 5 years
In some cases, investigators without an MD degree may be considered if their work demonstrates significant impact on clinical outcomes in diabetes care.
Career Interruption Consideration
Applicants who experienced career interruptions due to parenting, caregiving responsibilities, personal health issues, or COVID-related disruptions may request eligibility flexibility from program administrators.
Importance of the Award
This award plays a significant role in advancing the careers of early-stage clinician-scientists in diabetes research.
- It helps transition researchers from training to independent faculty roles.
- It strengthens the pipeline of clinical investigators in diabetes and endocrinology.
- It promotes innovation in patient-centered diabetes care.
- It improves the quality and relevance of type 1 diabetes clinical research.
How the Award Works
The application and funding process typically follows structured stages designed to ensure scientific quality and career development alignment.
- First, applicants confirm eligibility based on degree, appointment status, and research focus.
- Second, they design a patient-oriented type 1 diabetes clinical research project.
- Third, they prepare a detailed budget including allowable research costs and justification.
- Fourth, institutional support and approval are secured before submission.
- Finally, the complete application is submitted according to program guidelines.
Common Mistakes to Avoid
Applicants should avoid several common issues that can reduce competitiveness or lead to disqualification.
- Submitting research that does not involve direct human subject interaction
- Proposing studies outside the scope of type 1 diabetes
- Exceeding the indirect cost limit of 10%
- Providing weak justification for career development goals
- Applying outside the 5-year early-career eligibility window
- Missing required institutional support or documentation
Tips for a Strong Application
A strong application typically demonstrates clarity, focus, and strong alignment with program goals.
- Clearly define a clinically relevant research question in type 1 diabetes
- Emphasize patient impact and translational value
- Present a clear and realistic career development plan
- Include preliminary data when available
- Ensure budget justification is detailed and appropriate
- Align the proposal with current priorities in diabetes clinical research
Frequently Asked Questions (FAQ)
What type of research does this award support?
It supports patient-oriented clinical research in type 1 diabetes that involves direct interaction with human participants.
Who can apply for this award?
Early-career investigators with MD, DO, PsyD, or MD-PhD degrees working in clinical departments and conducting human subjects research.
What is the maximum funding available?
The award provides up to USD 200,000 per year for a maximum of 5 years.
Can non-MD researchers apply?
Yes, in exceptional cases if their research significantly contributes to clinical outcomes in diabetes care.
What defines an early-career investigator?
An investigator who received their first faculty-level appointment within the last 5 years.
Are international institutions eligible?
Yes, both domestic and international public, private, nonprofit, and eligible government institutions may apply.
Is direct patient involvement required?
Yes, the research must include direct interaction with human participants.
Conclusion
The Early Career Patient-Oriented Diabetes Research Award is a major funding opportunity supporting emerging clinician-scientists in type 1 diabetes research. It provides financial resources and structured career development support to help investigators transition into independent academic roles while advancing patient-focused diabetes research.
For more information, visit Breakthrough T1D.
